Search clinical trials for: Extavia®

Total 20065 results

Sanofi Pasteur, a Sanofi Company

Completed

Post-licensure Safety Surveillance Study of Menactra Vaccine When Administered As a 2-dose Schedule to Children

Meningitis | Meningococcal Infection

United States
Terumo Europe N.V.

Terminated

QuiremSpheres Observational Study (Hope166)

Liver, Cancer of, Non-Resectable

Netherlands, Germany
Smith & Nephew Orthopaedics AG

Completed

Prospective Single-center Long-term Observation of the SL-PLUS® MIA Stem (SL-PLUS MIA)

Primary Total Hip Arthroplasty
Prokidney
PPD; Iqvia Pty Ltd

Recruiting

A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Chronic Kidney Diseases | Type 2 Diabetes Mellitus

United States, Taiwan, United Kingdom, Canada, Australia
Jiong Wu
The First Affiliated Hospital with Nanjing Medical University; Second Affiliated... and other collaborators

Active, not recruiting

Study to Compare the Safety of Immediate One-stage IBBR With Expander-Implant Two-stage IBBR Augmented With TiLoop® Bra(COSTA) (IBBR)

Breast Cancer

China
Anika Therapeutics, Inc.

Completed

Safety and Effectiveness of Monovisc® Injection for Osteoarthritis of the Knee

Osteoarthritis

Canada, United States
Jazz Pharmaceuticals

Withdrawn

Investigation of Cognitive Outcomes With Cannabidiol Oral Solution (EPI-COG)

Lennox-Gastaut Syndrome
UCB Pharma

Terminated

Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction (ROADMAP)

Advanced Parkinson's Disease

United States
Amgen

Completed

Enbrel® in Psoriatic Arthritis

Psoriasis
AstraZeneca

Completed

Evaluation of Atacand® (Candesartan) in Daily Medical Practice

Hypertension
West German Study Group
Eli Lilly and Company; Genomic Health®, Inc.

Recruiting

Adjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic High Risk, HR+/HER2- EBC (ADAPTlate)

Breast Cancer Female

Germany
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...
Merck Hellas sa., Greece, an affiliate of Merck KGaA, Darmstadt, Germany

Active, not recruiting

Prospective Effectiveness and Safety Study of Cladribine in Participants Who Change First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS)

Multiple Sclerosis

Greece, Switzerland, Norway, Italy, Poland, Portugal
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...
Merck Serono Limited, an affiliate of Merck KGaA, Darmstadt, Germany

Completed

Effectiveness of Cladribine Tablets in Participants With Highly-active Relapsing Multiple Sclerosis (CAMELOT-MS)

Relapsing-Remitting Multiple Sclerosis

United Kingdom
Merck KGaA, Darmstadt, Germany

Completed

Evaluation of the Onset of Action in Highly Active MS (MAGNIFY)

Multiple Sclerosis

United Kingdom, Germany, Israel, Finland, Canada, Australia, Czechia, Spain, France, Italy, Austria, Hungary, Poland, Sweden
Assistance Publique - Hôpitaux de Paris

Terminated

Evaluation of the Clinical and Biological Consequences of Levothyrox® Formula Modification (FORTHYROX)

Thyroid Disorder

France
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine

Meningitis | Meningococcal Infection

United States
University Hospital, Basel, Switzerland

Completed

Melanoma Detection in Switzerland With VECTRA (MELVEC)

Melanoma (Skin)

Switzerland
Uludag University

Not yet recruiting

Which Technique is Effective in Reducing the Pain of Peripheral Intravenous Catheterization in Pediatric Patients, Infra-Red Light or Buzzy®?

Pain Management
Sanofi Pasteur, a Sanofi Company

Completed

Study of Fluzone® Influenza Virus Vaccines 2012-2013 Formulation Among Adults.

Influenza

United States
Sanofi Pasteur, a Sanofi Company

Completed

A Study to Assess the Safety of Adacel® Vaccine

Pertussis | Tetanus | Diphtheria

Vietnam
Taichung Veterans General Hospital
GlaxoSmithKline

Terminated

Comparison Between Lamivudine and Entecavir Treatment in Spontaneous Severe Acute Exacerbation (NUC115132)

Chronic Hepatitis B

Taiwan
Sanofi

Completed

Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants.

Pertussis | Tetanus | Diphtheria | Poliomyelitis | Haemophilus Influenzae Type B

Korea, Republic of
Southern California Institute for Research and...
Merck Sharp & Dohme LLC

Unknown

Pilot Study to Determine the Safety and Efficacy of Gardasil Against the Human Papilloma Virus (HPV) in HIV-infected Men (MIRB #862)

HIV Infections | Anal Cancer

United States
Ethicon, Inc.

Recruiting

Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System

Stress Urinary Incontinence

Poland, United States, Italy, Switzerland
Ethicon, Inc.

Recruiting

Post-Market Clinical Follow-Up onTVT EXACT® Continence System

Stress Urinary Incontinence

United States, Germany, Denmark, France, Austria, Sweden
Elusys Therapeutics
Centers for Disease Control and Prevention; APCER Life Sciences

Not yet recruiting

An Open Label Field Study of Anthim (Obiltoxaximab) in Subjects Exposed to B. Anthracis

Infection, Bacterial | Anthrax
Hospital General Universitario Gregorio Marañon

Completed

Evaluation of the Ambu® AuraGain in Ambulatory Surgery

Airway

Spain
Mustafa Kemal University

Withdrawn

Effect of Different Fixed Lingual Retainers on Tooth Stability

Effect of Lingual Retainers on Tooth Stability

Turkey
Astellas Pharma Inc

Completed

Long-Term Specified Drug Use-results Survey of Betanis Tablets

Overactive Bladder

Japan
Sanofi Pasteur, a Sanofi Company

Completed

Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® Vaccine

Influenza

United States
Sanofi Pasteur, a Sanofi Company

Completed

Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis Vaccine

Poliomyelitis | Polio

China
UCB Pharma

Completed

Placebo-controlled Study in Patients With Parkinson's Disease to Evaluate the Effect of Rotigotine on Non-motor Symptoms

Idiopathic Parkinson's Disease

Germany, Austria, Belgium, Bulgaria, Czech Republic, France, Hungary, Italy, Romania, Slovakia, Spain, Switzerland
Amgen

Completed

Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer | Lung Cancer
Amgen

Completed

Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)

Breast Cancer | Neutropenia | Fever
Merck KGaA, Darmstadt, Germany

Completed

Effects of Cladribine Tablets on the PK of Microgynon®

Relapsing Multiple Sclerosis (RMS)

Germany, Poland
Tilman S.A.
Artialis

Completed

Evaluation of FLEXOFYTOL® Versus PLACEBO (COPRA)

Osteoarthritis

Belgium
Hospices Civils de Lyon

Completed

Optical Biopsy and Fallopian Tube (FALLOPTIC)

Bilateral Laparoscopic Salpingectomy

France
Biogen
Elan Pharmaceuticals

Completed

Safety Study of Natalizumab to Treat Multiple Sclerosis (MS)

Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis

United States
AstraZeneca

Completed

EMR Data to Assess Monitoring of Patients Treated With Quetiapine

Schizophrenia | Bipolar Disorder | Major Depressive Disorder
Ministry of Health, Malaysia
Baxter Healthcare Corporation; Fresenius Medical Care North America

Completed

Open Label Trial to Establish the Equivalence Between ANDY-Disc® and Ultrabag® in Patients on CAPD.

Chronic Renal Failure

Malaysia
Sanofi Pasteur, a Sanofi Company

Completed

Study of Fluzone® Influenza Virus Vaccine 2011-2012 Formulation (Intramuscular Route) Among Adults

Influenza

United States
University Hospital, Clermont-Ferrand
Dr. Gisèle PICKERING (MCU, PH) Center of clinical pharmacology/CIC Inserm-1405... and other collaborators

Unknown

Concordance of Pain Detection in Patients by Doloplus® and Algoplus® Behavioural Scales (CALDOL)

Pain in Elderly Patients Having Communication Disorders.

France
SenoRx, Inc.
C. R. Bard

Terminated

Using the Conture® Multi-Lumen Balloon to Deliver Accelerated Partial Breast Brachytherapy

Breast Cancer

United States
UCB Pharma

Completed

Rotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs Syndrome (RLS) (RESTORE)

Restless Legs Syndrome

United States
UCB Pharma

Completed

Non-interventional Study (NIS) in Patients With Restless Legs Syndrome in Daily Practise (RLS-Practise)

Idiopathic Restless Legs Syndrome

Germany
Universita degli Studi della Basilicata
San Carlo Public Hospital, Potenza, Italy

Completed

Medical Cannabis for Treating Pain Related to Fibromyalgia (Bedrocan®-LD)

Fibromyalgia

Italy
Cagent Vascular LLC

Withdrawn

Serranator® Alto Post Market Clinical Follow Up (PMCF) Study

Peripheral Arterial Disease | Arteriovenous Graft | Arterio-venous Fistula
LEO Pharma
LEO Pharma GmbH, Neu-Isenburg, Germany

Completed

Efficacy, Tolerability and Handling of Daivobet® Gel in Patients With Psoriasis Vulgaris

Psoriasis Vulgaris

Germany
Sandoz

Completed

Safety and Efficacy of Omnitrope® (rhGH) in Short Children Born Small for Gestational Age (SGA)

Small for Gestational Age

Belgium, Czechia, Georgia, Hungary, Poland, Romania, Germany
Ulthera, Inc

Completed

Evaluation of the Ulthera® System for Treatment of the Brachia

Brachial Ptosis

United States

Search clinical trials for: Extavia®

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations